Deka Bank Deutsche Girozentrale Bridge Bio Pharma, Inc. Transaction History
Deka Bank Deutsche Girozentrale
- $54.1 Billion
- Q4 2024
A detailed history of Deka Bank Deutsche Girozentrale transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 100,000 shares of BBIO stock, worth $3.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$3.19 Million
Previous $2.48 Million
9.75%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BBIO
# of Institutions
298Shares Held
171MCall Options Held
10.4MPut Options Held
2.33M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$805 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$800 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$452 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$396 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$193 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.72B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...